Extended 10-Panel
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
The Zuiver phenibut urine screening provides targeted, qualitative detection of phenibut and its metabolites. This specialised test addresses a gap in standard panels, offering reliable results for extended workplace and clinical screening.
Doctor's Assessment Included
This test detects the presence of phenibut and its metabolites in urine. Phenibut is a GABA-B receptor agonist originally developed in Russia. The test provides a qualitative result indicating whether phenibut metabolites are present above the assay cut-off level.
Phenibut use may be associated with dependence, withdrawal symptoms, and adverse effects on the central nervous system. Because phenibut is often not included in standard drug panels, targeted testing can be important for accurate clinical assessment. Consult a healthcare professional for interpretation of results.
Testing may be relevant when phenibut use is suspected, during substance abuse treatment monitoring, or as part of an extended drug screening panel. Phenibut is increasingly encountered in clinical and forensic settings. Consult a healthcare professional for guidance.
Support your well-being through regular physical activity, adequate sleep, and stress management techniques. If you have concerns about supplement or substance use, consult a qualified healthcare professional. Avoid purchasing unregulated substances online.
Phenibut is typically not included in standard workplace drug screening panels. A specific, targeted test is required to detect its presence in urine. This is why dedicated phenibut screening may be requested in certain clinical or forensic situations.
The detection window for phenibut in urine may vary but is generally estimated at several days after use. Factors such as dosage, frequency of use, and individual metabolism can influence detectability. Consult a healthcare professional for details.
This marker is included in the following test panels.
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
Medical reviewer
Dr. Naimi oversees the medical standards behind our content and assessments.
Medical policyDoctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
Phenibut
€114,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy